Supply agreement signed with Region Östergötland for wound healing products

Report this content

Region Östergötland has announced that they intend to sign a direct purchase agreement for items within S2Medical AB (publ)’s wound healing portfolio. The region has not yet announced an estimated quantity or duration of the contract. Information regarding quantity and duration may be announced after the agreement is signed by both parties.


S2Medical's wound healing portfolio consists of several different products that facilitate all the phases of wound healing and contribute to a significantly improved quality of life, for the patients and a significantly reduced cost of care.


“Region Östergötland is our home region and therefore it is with excitement we start this collaboration to increase the quality of life for the patients in the region. We look forward to the opportunity to further strengthen the collaboration and to deliver from our entire portfolio of products”. Says Petter Sivlér CEO of the company


This disclosure contains information that S2Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 14-10-2022 12:25 CET.

Contact Details
Petter Sivlér – CEO, S2Medical AB (publ)
Telephone: +46 (0)8-70 000 50

Certified Adviser
Vator Securities AB
Telephone +46 (0)8-580 065 99

About S2Medical 

S2Medical AB (publ) is a medical technology company that develops and sells innovative wound healing products for the entire wound healing process, with a focus on burns and chronic wounds. The company has developed eiratex®, a new cellulose-based material for healing severe burns and chronic wounds. The material heals wounds effectively and thereby reduces both suffering for patients and costs for health care.

Share's ticker: S2M

Share's ISIN-code: SE0011725084


Documents & Links